Biochemically Recurrent Prostate Carcinoma

specific

Increasing prostate-specific antigen (PSA) following prostatectomy or radiation therapy in a patient with a history of localized prostate carcinoma. Signs of metastasis are absent using the currently available scanning technology.

34

Centers

36

Active Trials

Cancer Funding

Top Centers for Biochemically Recurrent Prostate Carcinoma(34)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.6
2
High-Volume Research Center
72.6
3
NCI Comprehensive
Active Research Program
50.1
4
NCI Comprehensive
Active Research Program
50.1
5
NCI Comprehensive
Active Research Program
50.1
6
NCI Comprehensive
Active Research Program
50.1
7
NCI Comprehensive
Active Research Program
50.1
8
NCI Comprehensive
Active Research Program
50.1
9
NCI Comprehensive
Active Research Program
50.1
10
NCI Comprehensive
Active Research Program
50.1
11
NCI Comprehensive
Active Research Program
50.1
12
NCI Comprehensive
Active Research Program
50.1
1350.1
14
NCI Comprehensive
Active Research Program
50.1
15
NCI Comprehensive
Active Research Program
50.1
16
NCI Comprehensive
Active Research Program
50.1
17
NCI Comprehensive
Active Research Program
50.1
18
NCI Comprehensive
Active Research Program
50.1
19
NCI Comprehensive
Active Research Program
50.1
20
NCI Comprehensive
Active Research Program
50.1
21
NCI Comprehensive
Active Research Program
50.1
22
NCI Clinical
Active Research Program
50.1
23
NCI Comprehensive
Active Research Program
50.1
24
NCI Comprehensive
Active Research Program
50.1
25
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
50.1
26
Active Research Program
50.1
27
Active Research Program
50.1
28
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
50.1
29
Active Research Program
50.1
30
Active Research Program
50.1
31
Active Research Program
50.1
32
Active Research Program
50.1
33
Active Research Program
50.1
34
Active Research Program
50.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →